Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options
Focus · 2021-06 · 19 (2) · 222-242
DOI: 10.1176/appi.focus.19203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Focus, 2021-06. Verfasst von Amir Garakani und 6 weiteren Autor:innen. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 247 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- NCATS NIH HHS
Zitieren
APA
Garakani, A., Murrough, J. W., Freire, R. C., Thom, R. P., Larkin, K., Buono, F. D., & Iosifescu, D. V. (2021). Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Focus, 19(2), 222-242. https://doi.org/10.1176/appi.focus.19203
Vancouver
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, et al. Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options. Focus. 2021;19(2):222-242. doi:10.1176/appi.focus.19203
BibTeX
@article{Garakani2021,
author = {Garakani, Amir and Murrough, James W and Freire, Rafael C and Thom, Robyn P and Larkin, Kaitlyn and Buono, Frank D and Iosifescu, Dan V},
title = {Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options},
journal = {Focus},
year = {2021},
volume = {19},
number = {2},
pages = {222--242},
doi = {10.1176/appi.focus.19203}
}
EUVIMED